Synapse Open Synapse
Biology

Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease

Cell Stem Cell · · 59 min read

Bratt-Leal et al. report the preclinical data supporting initiation of a clinical trial investigating autologous dopaminergic neuron precursor cell therapy for moderate to advanced Parkinson’s disease patients.

Latest from Cell Stem Cell